Interleukin-1 beta polymorphisms are associated with lymph node metastasis in korean patients with papillary thyroid carcinoma

Immunological Investigations

Volumn 41, Issue 8, 2012, Pages 888-905

  Ban, Ju Yeon ^a   Kim, Mi Kyung ^b   Park, Sung Wook ^b   Kwon, Kee Hwan ^c  

^a Institute of Tissue Regeneration Engineering   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Hallym University College of Medicine   (South Korea)

Author keywords

Haplotype; IL 1B; Lymph node metastasis; Papillary thyroid carcinoma; Polymorphism

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENOTYPE; HUMAN; INTERLEUKIN 1BETA GENE; KOREA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CARCINOMA;

ADULT; AGED; CARCINOMA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; THYROID NEOPLASMS;

EID: 84870874557     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2012.724751     Document Type: Article

References (41)

1. Arlt, A., Vorndamm, J., Muerkoster, S., Yu, H., Schmidt, W. E., Folsch, U. R., Schafer, H. (2002). Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res. 62(3):910-916.
2. Baune, B. T., Dannlowski, U., Domschke, K., Janssen, D. G., Jordan, M. A., Ohrmann, P., Bauer, J., Biros, E., Arolt, V., Kugel, H., Baxter, A. G., Suslow, T. (2010). The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol. Psych. 67(6):543-549.
3. Berulava, T., Horsthemke, T. (2010). The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. Eur. J. Hum. Genet. 18(9):1054-1056.
4. Carty, C. L., Heagerty, P., Heckbert, S. R., Enquobahrie, D. A., Jarvik, G. P., Davis, S., Tracy, R. P., Reiner, A. P. (2009). Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study. J. Atheroscler. Thromb. 16(4):419-430.
5. Chang, Y. W., Jang, J. Y., Kim, N. H., Lee, J. W., Lee, H. J., Jung, W. W., Dong, S. H., Kim, H. J., Kim, B. H., Lee, J. I., Chang, R. (2005). Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int. J. Cancer 114(3):465-471.
6. Coussens, L. M., Werb, Z. (2002). Inflammation and cancer. Nature 420(6917):860-867.
7. Czene, K., Lichtenstein, P., Hemminki, K. (2002). Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int. J. Cancer 99(2):260-266.
8. Dinarello, C. A. (1996). Biologic basis for interleukin-1 in disease. Blood 87(6):2095-2147.
9. Dinarello, C. A. (2010). Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev. 29(2):317-329.
10. El-Omar, E. M., Carrington, M., Chow, W. H., McColl, K. E., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C. C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J. F., Jr., Rabkin, C. S. (2000). Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776):398-402.
11. Enquobahrie, D. A., Rice, K., Williams, O. D., Williams, M. A., Gross, M. D., Lewis, C. E., Schwartz, S. M., Siscovick, D. S. (2009). IL1B genetic variation and plasma C-reactive protein level among young adults: The CARDIA study. Atherosclerosis 202(2):513-520.
12. Erdogan, M., Karadeniz, M., Ozbek, M., Ozgen, A. G., Berdeli, A. (2008). Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population. J. Endocrinol. Invest. 31(9):750-754.
13. Eun, Y. G., Hong, I. K., Kim, S. K., Park, H. K., Kwon, S., Chung, D. H., Kwon, K. H. (2011). A polymorphism (rs1801018, Thr7Thr) of BCL2 is associated with papillary thyroid cancer in Korean population. Clin. Exp. Otorhinolaryngol. 4(3):149-154.
14. Eun, Y. G., Shin, I. H., Kim, M. J., Chung, J. H., Song, J. Y., Kwon, K. H. (2012). Associations between promoter polymorphism-106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population. Surgery 151(2):323-329.
15. Hahn, W. H., Cho, B. S., Kim, S. D., Kim, S. K., Kang, S. (2009). Interleukin-1 cluster gene polymorphisms in childhood IgA nephropathy. Pediatr. Nephrol. 24(7):1329-1336.
16. Hefler, L. A., Ludwig, E., Lebrecht, A., Zeillinger, R., Tong-Cacsire, D., Koelbl, H., Leodolter, S., Tempfer, C. B. (2002). Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. J. Soc. Gynecol. Investig. 9(6):386-390.
17. Hirankarn, N., Kimkong, I., Kummee, P., Tangkijvanich, P., Poovorawan, Y. (2006). Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J. Gastroenterol. 12(5):776-779.
18. Ito, H., Kaneko, K., Makino, R., Konishi, K., Kurahashi, T., Yamamoto, T., Katagiri, A., Kumekawa, Y., Kubota, Y., Muramoto, T., Mitamura, K., Imawari, M. (2007). Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol. Rep. 18(2):473-481.
19. Ito, L. S., Iwata, H., Hamajima, N., Saito, T., Matsuo, K., Mizutani, M., Iwase, T., Miura, S., Okuma, K., Inoue, M., Hirose, K., Tajima, K. (2002). Significant reduction in breast cancer risk for Japanese women with interleukin 1B-31 CT/TT relative to CC genotype. Jpn. J. Clin. Oncol. 32(10):398-402.
20. Jazdzewski, K., Boguslawska, J., Jendrzejewski, J., Liyanarachchi, S., Pachucki, J., Wardyn, K. A., Nauman, A., de la Chapelle, A. (2011). Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC). J. Clin. Endocrinol. Metab. 96(3):E546-553.
21. Krelin, Y., Voronov, E., Dotan, S., Elkabets, M., Reich, E., Fogel, M., Huszar, M., Iwakura, Y., Segal, S., Dinarello, C. A., Apte, R. N. (2007). Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res. 67(3):1062-1071.
22. Landvik, N.E., Hart, K., Skaug, V., Stangeland, L. B., Haugen, A., Zienolddiny, S.(2009). A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis 30(7):1186-1192.
23. Lewis, A. M., Varghese, S., Xu, H., Alexander, H. R. (2006). Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med. 4:48.
24. Lewis, C. M. (2002). Genetic association studies: design, analysis and interpretation. Brief Bioinform. 3(2):146-153.
25. Lin, X. D., Chen, S. Q., Qi, Y. L., Zhu, J. W., Tang, Y., Lin, J. Y. (2012). Polymorphism of THBS1 rs1478604 A>G in 5-untranslated region is associated with lymph node metastasis of gastric cancer in a Southeast Chinese population. DNA Cell Biol. 31(4):511-519.
26. Liu, J., Zhai, X., Jin, G., Hu, Z., Wang, S., Wang, X., Qin, J., Gao, J., Ma, H., Wei, Q., Shen, H. (2006). Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int. J. Cancer 118(10):2554-2558.
27. Liu, X., Wang, Z., Yu, J., Lei, G., Wang, S. (2010). Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis. Breast Cancer Res. Treat. 124(3):821-825.
28. Liu, Y. H., Chen, R. H., Wu, H. H., Liao, W. L., Chen, W. C., Tsai, Y., Tsai, C. H., Wan, L., Tsai, F. J. (2010). Association of interleukin-1beta (IL1B) polymorphisms with Graves' ophthalmopathy in Taiwan Chinese patients. Invest. Ophthalmol. Vis. Sci. 51(12):623-6246.
29. Maihofner, C., Charalambous, M. P., Bhambra, U., Lightfoot, T., Geisslinger, G., Gooderham, N. J. (2003). Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis 24(4):665-671.
30. Maksymowych, W. P., Rahman, P., Reeve, J. P., Gladman, D. D., Peddle, L., Inman, R. D. (2006). Association of the IL1 gene cluster with susceptibility to ankylosing spondy-litis: an analysis of three Canadian populations. Arthritis Rheum. 54(3):974-985.
31. Motoyama, S., Miura, M., Hinai, Y., Maruyama, K., Usami, S., Saito, H., Minamiya, Y., Satoh, S., Murata, K., Suzuki, T., Ogawa, J. (2009). CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer. Ann. Surg. Oncol. 16(9):2479-2485.
32. Mukhopadhyay, P., Ali, M. A., Nandi, A., Carreon, P., Choy, H., Saha, D. (2006). The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells. Cancer Res. 66(3):1758-1766.
33. Nagataki, S., Nystrom, E. (2002). Epidemiology and primary prevention of thyroid cancer. Thyroid 12(10):889-896.
34. Ozgen, A. G., Karadeniz, M., Erdogan, M., Berdeli, A., Saygili, F., Yilmaz, C. (2009). The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients. J. Endocrinol. Invest. 32(6):491-494.
35. Park, J. K., Lee, S. M., Kang, W. S., Kim, S. K., Cho A. R. (2011). NGF polymorphisms and haplotypes are associated with schizophrenia in Korean population. Mol. Cell. Toxicol. 7(4):375-380.
36. Solovieva, S., Kamarainen, O. P., Hirvonen, A., Hamalainen, S., Laitala, M., Vehmas, T., Luoma, K., Nakki, A., Riihimaki, H., Ala-Kokko, L., Mannikko, M., Leino-Arjas, P. (2009). Association between interleukin 1 gene cluster polymorphisms and bilateral distal interphalangeal osteoarthritis. J. Rheumatol. 36(9):1977-1986.
37. Stern, A. G., de Carvalho, M. R., Buck, G. A., Adler, R. A., Rao, T. P., Disler, D., Moxley, G. (2003). Association of erosive hand osteoarthritis with a single nucleotide polymorphism on the gene encoding interleukin-1 beta. Osteoarthritis Cartilage 11(6):394-402.
38. Wang, Y. X., Zhao, L., Wang, X. Y., Liu, C. M., Yu, S. G. (2011). Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population. Endocrine 41(3):526-531.
39. Wolf, J. S., Chen, Z., Dong, G., Sunwoo, J. B., Bancroft, C. C., Capo, D. E., Yeh, N. T., Mukaida, N., Van Waes, C. (2001). IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin. Cancer Res. 7(6):1812-1820.
40. Wu, S., Lu, S., Tao, H., Zhang, L., Lin, W., Shang, H., Xie, J. (2011). Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer. J. Huazhong Univ. Sci. Technolog. Med. Sci. 31(1):114-119.
41. Zienolddiny, S., Ryberg, D., Maggini, V., Skaug, V., Canzian, F., Haugen, A. (2004). Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int. J. Cancer 109(3):353-356.